View drug registration information details.
Items | Registration information |
ID | 369 |
No | 369 |
Brand Name | OMEPAZ |
Ingredients | OMEPRAZOLE SODIUM EQ. TO OMEPRAZOLE 40 MG |
Dosage Form | POWDER FOR SOLUTION FOR INJECTION |
Primary Packaging | VIAL |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 1 VIAL AND 1 AMPOULE WITH 10 ML WATER FOR INJECTION |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | TREATMENT OF DUODENAL ULCERS, PREVENTION OF RELAPSE OF DUODENAL ULCERS, TREATMENT AND PREVENTION OF RELAPSE OF GASTRIC ULCERS, TREATMENT AND PREVENTION OF NSAID-ASSOCIATED GASTRIC AND DUODENAL ULCERS IN PATIENTS AT RISK, TREATMENT OF REFLUX OESOPHAGITIS, TREATMENT OF ZOLLINGER-ELLISON SYNDROME. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE OR ALMOST WHITE LOOSE POWDER |
Note | |
License Owner | CBF PHARMA CO.,LTD |
Manufacturer | CISEN PHARMACEUTICAL CO.,LTD |
Country | CHINA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 11 I 3926/13 |
FDD Registration Date | 14-AUG-2023 |
Expiry Date | 13-AUG-2026 |
Back to drug list
|